Cost Effectiveness of a Potential Vaccine for Human papillomavirus
Human papillomavirus (HPV) infection, usually a sexually transmitted disease, is a risk factor for cervical cancer. Given the substantial disease and death associated with HPV and cervical cancer, development of a prophylactic HPV vaccine is a public health priority. We evaluated the cost-effectiven...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Centers for Disease Control and Prevention
2003-01-01
|
| Edice: | Emerging Infectious Diseases |
| Témata: | |
| On-line přístup: | https://wwwnc.cdc.gov/eid/article/9/1/02-0168_article |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|